CEFEPIME IN RESPIRATORY TRACT INFECTION
スポンサーリンク
概要
- 論文の詳細を見る
Cefepime was used in 11 patients with respiratory tract infection. The patients received the drug for 5-14 days at a dose of 2g/day. The clinical response was 87.5%(7/8) in 8 patients with chronic airway infection and the overall efficacy rate was good; 81.8%. Bacteriologically, of 8 strains in which the causative organisms were isolated, (3 strains of Gram-positive cocci and 5 of Gramnegative rods), 6 were eradicated and 2 were persisted. No side effects were seen, and only one abnormal laboratory finding was noted, namely a transitory slight increase of GOT and GPT.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.